Literature DB >> 9237085

Health effects of emotional disclosure in rheumatoid arthritis patients.

J E Kelley1, M A Lumley, J C Leisen.   

Abstract

This study examined the effects of emotional disclosure of stressful events on the pain, physical and affective dysfunction, and joint condition of patients with rheumatoid arthritis (RA). Patients were randomly assigned to talk privately about stressful events (disclosure group, n = 36) or about trivial topics (control group, n = 36) for 4 consecutive days. Disclosure resulted in immediate increases in negative mood. At 2 weeks the 2 groups did not differ on any health measure, but at 3 months disclosure patients had less affective disturbance and better physical functioning in daily activities. There was no main effect of disclosure on pain or joint condition, but among the disclosure patients, those who experienced larger increases in negative mood after talking demonstrated improvements in the condition of their joints. This study concludes that, among RA patients, verbal disclosure and emotional processing of stressful life events induces an immediate negative mood followed by improved psychological functioning.

Entities:  

Mesh:

Year:  1997        PMID: 9237085     DOI: 10.1037//0278-6133.16.4.331

Source DB:  PubMed          Journal:  Health Psychol        ISSN: 0278-6133            Impact factor:   4.267


  24 in total

1.  Disease severity and domain-specific arthritis self-efficacy: relationships to pain and functioning in patients with rheumatoid arthritis.

Authors:  Tamara J Somers; Rebecca A Shelby; Francis J Keefe; Neha Godiwala; Mark A Lumley; Angelia Mosley-Williams; John R Rice; David Caldwell
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-06       Impact factor: 4.794

2.  The health effects of at-home written emotional disclosure in fibromyalgia: a randomized trial.

Authors:  Mazy E Gillis; Mark A Lumley; Angelia Mosley-Williams; James C C Leisen; Timothy Roehrs
Journal:  Ann Behav Med       Date:  2006-10

3.  Effects of day-to-day affect regulation on the pain experience of patients with rheumatoid arthritis.

Authors:  Mark Connelly; Francis J Keefe; Glenn Affleck; Mark A Lumley; Timothy Anderson; Sandra Waters
Journal:  Pain       Date:  2007-02-23       Impact factor: 6.961

4.  Depressive Symptoms, Disclosure, HIV-Related Stigma, and Coping Following HIV Testing Among Outpatients in Uganda: A Daily Process Analysis.

Authors:  Susan M Kiene; Meredith Dove; Rhoda K Wanyenze
Journal:  AIDS Behav       Date:  2018-05

Review 5.  Anger inhibition and pain: conceptualizations, evidence and new directions.

Authors:  John W Burns; Phillip J Quartana; Stephen Bruehl
Journal:  J Behav Med       Date:  2008-05-23

6.  The Pain of Ambivalence over Emotional Expression.

Authors:  Carol Wang; Celia C Y Wong; Qian Lu
Journal:  Int J Behav Med       Date:  2018-04

7.  Partner-assisted emotional disclosure for patients with GI cancer: 8-week follow-up and processes associated with change.

Authors:  Laura S Porter; Francis J Keefe; Donald H Baucom; Herbert Hurwitz; Barry Moser; Emily Patterson; Hong Jin Kim
Journal:  Support Care Cancer       Date:  2011-09-24       Impact factor: 3.603

8.  Gender-specific effects of an augmented written emotional disclosure intervention on posttraumatic, depressive, and HIV-disease-related outcomes: a randomized, controlled trial.

Authors:  Gail Ironson; Conall O'Cleirigh; Jane Leserman; Rick Stuetzle; Joanne Fordiani; MaryAnn Fletcher; Neil Schneiderman
Journal:  J Consult Clin Psychol       Date:  2012-12-17

Review 9.  Emotional disclosure interventions for chronic pain: from the laboratory to the clinic.

Authors:  Mark A Lumley; Elyse R Sklar; Jennifer N Carty
Journal:  Transl Behav Med       Date:  2012-03       Impact factor: 3.046

10.  Emotion regulation in patients with rheumatic diseases: validity and responsiveness of the Emotional Approach Coping Scale (EAC).

Authors:  Heidi A Zangi; Andrew Garratt; Kåre Birger Hagen; Annette L Stanton; Petter Mowinckel; Arnstein Finset
Journal:  BMC Musculoskelet Disord       Date:  2009-09-03       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.